A repository & source of cutting edge news about emerging terahertz technology, it's commercialization & innovations in THz devices, quality control, process control, medical diagnostics, security, astronomy,communications, graphene, metamaterials, CMOS, compressive sensing,3d printing, and the Internet of Everything. NOTHING POSTED IS INVESTMENT ADVICE! REPOSTED COPYRIGHT IS FOR EDUCATIONAL USE. I am a private investor in THz.
Wednesday, September 3, 2014
Terahertz reflectometry identifies early skin cancer
Applied Research & Photonics (ARP; Harrisburg, PA) is applying its terahertz-reflectometry systems—which have also been used for multilayer paint-thickness analysis and fault detection in silicon chips—to the identification of early-stage skin cancer. In the experimental setup, both benign and basal cell carcinoma (BCC) skin samples are analyzed using terahertz reflectometry, terahertz time-domain spectroscopy, and terahertz imaging. The electro-optic dendrimer (EOD)-based continuous-wave (CW) terahertz source—which emits broadband energy from 1 THz to approximately 35 THz—exploits a mechanism invented by ARP called dendrimer dipole excitation (DDE). This mechanism stems from the fact that the EOD has a high electro-optic coefficient (around 130 pm/V) and thus offers high conversion efficiency.
The terahertz source is reflected off the highly layered structure of human skin and the layering information is obtained by subtracting the reflected intensity data from the baseline (empty cell) data. Data analysis reveals that healthy skin is evenly layered while the layering pattern of cancerous cells is significantly diminished, indicating cell agglomeration and/or tumor formation. Measurements with an ARP TeraSpectra spectrometer confirm that healthy skin produces a terahertz spectrum that is different than diseased skin. A reconstructive-imaging algorithm is used to create 3D skin images that confirm healthy skin exhibits a regular cellular pattern while the cancerous tissue is amorphous. The noninvasive technique could eliminate the need for biopsy as the main mode of skin-cancer diagnosis. Contact Anis Rahman email@example.com.